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Using cannabis is perceived by many as relatively harmless, but the adverse effects of problematic
cannabis use are significant. Thirteen million individuals globally have Cannabis Use Disorders
(CUDs; UNODC, 2015), with relapse rates comparable to those of other substance use disorders
(∼52–70%; Budney et al., 1999; Chauchard et al., 2013). Contrasting non-problematic recreational
cannabis use, severe forms of CUD involve compulsive use despite significant harms to mental
health; high stress levels (craving, withdrawal); cognitive deficits; academic and work absenteeism;
and significant risky behaviors, such as driving and operating machinery while intoxicated.
Worryingly, the concentration of 19 -tetrahydrocannabinol, the compound driving the addiction
liability of cannabis, has risen in cannabis products over the past decade (UNODC, 2015).

NEUROCOGNITIVE MECHANISMS UNDERLYING CUDS: WHAT
WE KNOW AND WHAT WE DO NOT KNOW
Mounting (although mixed) evidence shows that regular cannabis use is linked to abnormal
neurobiology (Lorenzetti et al., 2014) in regions subserving reward, craving/urges, and cognitive
control—key components of addiction (Everitt and Robbins, 2005). Neurobiological studies of
CUDs specifically are sparse and limited because diagnostic assessments of CUDs are rarely
performed (Lorenzetti and Cousijn, 2015). There is a strong need to study CUDs, given their high
prevalence and treatment demands, and worldwide trends toward legalizing cannabis products.
Emerging evidence shows neuroadaptations in cannabis users with CUDs (Lorenzetti and
Cousijn, 2015), which may be related to the development of addictive behaviors (i.e., reduced
prefrontal control, alteration in reward systems, and increased stress, anxiety, and withdrawal).
CUDs may exacerbate and expand the neurobiological alterations associated with pre-existing
general vulnerability to drug use and recreational cannabis use, particularly in addiction-relevant
areas (Ersche et al., 2010). Neurobiological models propose mechanisms of addiction related
neuroadaptations within distinct brain regions in the transition from recreational, non-problem,
and reward-driven drug use (ventral striatum, medial prefrontal cortex) to compulsive and habitual
drug use (dorsal striatum, lateral prefrontal cortex, stress circuit; Everitt and Robbins, 2005,
2013). Specific aspects of severe CUDs (e.g., neural signatures of withdrawal, stress, craving, and
compulsive use) may dissociate from the direct effects of cannabis exposure in milder forms of
CUDs (e.g., possibly limited to brain areas high in cannabinoid receptors). This notion is yet
to be tested. Neurobiological models of addiction and the transition from regular heavy use to
compulsive drug use mostly rely on preclinical evidence from artificially induced drug taking of
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substances other than cannabis such as cocaine (Ito et al.,
2002; Vanderschuren et al., 2005; See et al., 2007). Emerging
evidence in human cocaine users has elucidated neural network
changes involved in compulsive drug use at the level of
frontal-striatal circuits and these neural changes have been
linked to drug relapse, validating preclinical models of drug
addiction (Contreras-Rodríguez et al., 2015; Hu et al., 2015).
Supportive evidence for these models also comes from a study
of alcohol dependent individuals (Vollstädt−Klein et al., 2010)
and functional imaging studies in cannabis users (Filbey and
Dunlop, 2014; Vingerhoets et al., 2016) implicating frontal–
striatal pathways. Most human studies of cannabis users,
however, compare groups of heavy cannabis users with varying
levels of cannabis related problems to controls without assessing
CUD severity with rigorous diagnostic instruments. As such,
little is known about the neurobiology underlying cannabis
addiction.
Addiction-specific neural alterations—rather than those
associated with use per se—are likely to predict negative
outcomes in cannabis users. Consistent with this notion,
dependent users have worse mental health outcomes than
non-dependent users (Van der Pol et al., 2013b,c). Moreover,
severity of cannabis use-related problems—rather than quantity
of use—predicts activity in reward-related brain regions in
response to cannabis cues, which is a well-validated measure of
craving (Cousijn et al., 2013). Uncovering whether CUDs involve
neuroadaptations dissociable from those linked to recreational,
non-problem cannabis use is critical.

detailed information on cannabis use (daily/almost daily use,
duration, and age of onset); objective (i.e., biological specimens)
quantification of cannabinoids (Lorenzetti et al., 2016); cognitive
and brain anatomy/function (using MRI); and recruitment
approaches that maximize sample representativeness (e.g., the
general community, coffee shops; Van der Pol et al., 2011).
Notable examples include the Netherlands XTC Toxicity (NeXT)
study (De Win et al., 2005), the USA ABCD study http://
addictionresearch.nih.gov/abcd-study and the Dutch Cannabis
Dependence Study (CanDep; Van der Pol et al., 2011).
As longitudinal studies are very expensive and time
consuming, we can address relevant research questions (i)–
(vi) in a timely fashion, via re-examination, online data sharing,
and follow up from already collected neuroscientific datasets
on cannabis using cohorts with varying levels of problems
with use. Problem vs. recreational users may be segregated
(to enable their comparison) using information available from
each study’s instruments, on key addiction phenotypes (e.g.,
craving, withdrawal, difficulties in controlling use, persistent
use despite harmful consequences on mental health, and sociooccupational functioning, higher priority given to drug use than
to other activities and obligations; APA., 2013; WHO, 2016). A
notable example of this includes the internationally coordinated
initiative ENIGMA Addiction Working Group (Mackey et al.,
2016).
Finally, we propose the development of an agreed-upon
instrument to objectively assess key features of cannabis
addiction vs. non-problem use in neuroscientific settings, as most
measures of cannabis related problems are borrowed from those
used for other substances, the features of which may not fit those
relevant to cannabis dependence (Lorenzetti et al., 2016). To this
end, a Delphi review (Dalkey and Helmer, 1963) with worldclass experts in the clinical/neuroscientific aspects of cannabis
and substance dependence may be conducted and may identify
additional hot topics in CUDs.
In conclusion, we call for a greater, systematic and coordinated
research effort internationally, to identify pathways in and out of
CUDs and fill the existing gap between the limited knowledge on
CUDs and the increasing availability of cannabis products.

SUGGESTIONS FOR FUTURE STUDIES
Important steps to resolve addiction vs. exposure dependent
alterations in cannabis users include the characterization of
the neural, behavioral, polygenic risk markers, and epigenetics
(Sherva et al., 2016; Walters and Owen, 2016) that identify (i)
which recreational cannabis users or cannabis naïve individuals
are vulnerable to develop a CUD; (ii) the recreational nonproblem cannabis users en route to develop a severe CUD; (iii)
which users have persistent severe CUDs (Van der Pol et al.,
2013a); (iv) which users transit to a lower severity CUD/nonproblem cannabis use/abstinence; and (v) sex differences in the
development of CUDs, as females are underrepresented in the
existing literature, while presenting a distinct profile from males
(e.g., faster transition to dependence, more treatment resistant;
Lorenzetti and Carter, 2015).
Twin studies are required to address the above research
question (i) and disentangle epigenetic factors that confer risk
to develop CUDs in some but not others (Gillespie et al.,
2009). Large-scale longitudinal studies are warranted to address
research questions (i)–(v) and track young adolescents yet
naïve to cannabis through to late adulthood. Such studies
should combine diagnostic cutoffs that inform on the clinical
significance of cannabis use (i.e., DSM 5, ICD-10); self-reported
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